EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma

Marzia Salgarello iD, Jaroslaw Krupa iD, Rebecca Allchin, Simon Pilgrim iD, Fiona Miall iD, Arianna Di Napoli iD, Maurizio Martelli iD, Giulio Tarantino iD

Archives of Plastic Surgery · 01.01.2025 · 52 (01) · 011-020

DOI: 10.1055/a-2427-2066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Plastic Surgery, erschienen am 01.01.2025. Verfasst von Marzia Salgarello und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Università Cattolica del Sacro Cuore, Rome, Italy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare form of non-Hodgkin T-cell lymphoma diagnosed in patients with a history of breast implants. Most patients develop a periprosthetic effusion at early stages of disease while less common presentations include a palpable mass, severe capsular contracture, lymphadenopathy, or cutaneous erythema. Due to the complex nature of this disease, a multidisciplinary approach is necessary for optimal management, particularly in locally advanced disease or inoperable patients. We present the successful use of neoadjuvant therapeutic protocols in two cases of locally advanced BIA-ALCL. The first case was a 52-year-old patient with a left breast mass-like stage III disease who underwent combined targeted immunotherapy and chemotherapy (brentuximab vedotin [BV]–cyclophosphamide, doxorubicin, prednisone [CHP]). Following a complete radiological and metabolic response, the patient underwent bilateral implant removal, right total intact capsulectomy, left en bloc capsulectomy, and skin resection from the left inframammary fold in continuity with the capsule. The second case was a 65-year-old patient with right breast swelling and mass-like stage IIA disease who received targeted immunotherapy, BV. Following a complete metabolic response, she underwent bilateral implant removal and en bloc capsulectomy. A literature review and the reported cases suggest the effectiveness of targeted immunotherapy as monotherapy or in combination with chemotherapy in locally advanced BIA-ALCL in disease downstaging, surgical de-escalation, reduction of significant postoperative complications, and an acceptable tolerance profile. Although surgery is an essential part of treatment, the timing and type of intervention should be carefully planned, especially when primary, radical resection is uncertain.

Schlagwörter

Stichwörter der Autor:innen

breast implantbreast implant-associated anaplastic large cell lymphomabrentuximab vedotincapsulectomyneoadjuvant therapy

Autor:innen und Institutionen

  • Department of Plastic Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, Leicester, United Kingdom of Great Britain and Northern Ireland.
  • Department of Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom of Great Britain and Northern Ireland.
  • Department of Clinical and Molecular Medicine, Sapienza University, Sant'Andrea University Hospital, Rome, Italy.
  • Group of Experts on BIA-ALCL, Istituto Superiore di Sanità, Roma, Lazio, Italy.
  • Department of Translational and Precision Medicine, Umberto I Policlinico di Roma, Roma, Lazio, Italy.

ORCID-Profile: Marzia Salgarello, Jaroslaw Krupa, Simon Pilgrim, Fiona Miall, Arianna Di Napoli, Maurizio Martelli, Giulio Tarantino

Zitieren

APA

Salgarello, M., Krupa, J., Allchin, R., Pilgrim, S., Miall, F., Napoli, A. D., Martelli, M., & Tarantino, G. (2025). Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma. Archives of Plastic Surgery, 52(01), 011-020. https://doi.org/10.1055/a-2427-2066

Vancouver

Salgarello M, Krupa J, Allchin R, Pilgrim S, Miall F, Napoli AD, et al. Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma. Archives of Plastic Surgery. 2025;52(01):011-020. doi:10.1055/a-2427-2066

BibTeX
@article{Salgarello2025,
  author = {Salgarello, Marzia and Krupa, Jaroslaw and Allchin, Rebecca and Pilgrim, Simon and Miall, Fiona and Napoli, Arianna Di and Martelli, Maurizio and Tarantino, Giulio},
  title = {Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma},
  journal = {Archives of Plastic Surgery},
  year = {2025},
  volume = {52},
  number = {01},
  pages = {011--020},
  doi = {10.1055/a-2427-2066}
}
Kostenlos starten →